-
Mashup Score: 2
Carlson and Nelson Endowed Director, Center for Individualized Medicine, and Vasek and Anna Maria Polak Professor of Cancer Research, Mayo Clinic in Scottsdale, Arizona (Author’s note: The other biggest losers appearing herein will remain nameless and will owe me a nice dinner for sparing them, but more on that later …) It comes with the territory in academic hematology: Early career aspirations to have an impact gradually get noticed, and when the first speaking invitations arrive, they are both gratifyin
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1M-POWER | Actor and Artist Ice-T Raises Awareness of Myeloma in the Black Community - 3 month(s) ago
Renowned actor and artist Ice-T joins hands with the International Myeloma Foundation to raise awareness of myeloma in the black community this Black History…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
RT @NorthTxMSG: Full video 👇🏽... whre ICE-T describes our M-Power initiative led by @jmikhaelmd https://t.co/zSVjJMk1hv
-
-
Mashup Score: 1
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: General Medicine News, Hematologists1Tweet-
4/#MedTwitter #MMsm 🏅#CME➡️https://t.co/DuDs25uHM5 🔴Post-Poll Q 3️⃣ 📊RE: monitoring plans for pts receiving bispecific antibodies for #RRMM 👀Monitoring for which of the following AEs should be included for #talquetamab but not for #elranatamab or #teclistamab?
-
-
Mashup Score: 2RRMM — Current Activities - 6 month(s) ago
Riding the Wave | Differentiating Bispecifics and CAR-T for Relapsed Refractory Multiple Myeloma Expert Consult #1: Selecting BCMA- and GPRC5D-Directed Therapies This activity is jointly provided by Global Education Group and Bonum…
Source: www.bonumce.comCategories: General Medicine News, Hem/OncsTweet-
2/#MedTwitter #MMsM 🏅#CME➡️https://t.co/1p3o9jnnGx 🟢#PreSurvey Q 1️⃣ 📊Which of the following has demonstrated the longest median progression-free survival in phase1️⃣ studies of pts w/ #RRMM?
-
-
Mashup Score: 2RRMM — Current Activities - 6 month(s) ago
Riding the Wave | Differentiating Bispecifics and CAR-T for Relapsed Refractory Multiple Myeloma Expert Consult #1: Selecting BCMA- and GPRC5D-Directed Therapies This activity is jointly provided by Global Education Group and Bonum…
Source: www.bonumce.comCategories: General Medicine News, Hem/OncsTweet-
2/#MedTwitter #MMsM 🏅#CME➡️https://t.co/1p3o9jnnGx 🟢#PreSurvey Q 1️⃣ 📊Which of the following has demonstrated the longest median progression-free survival in phase1️⃣ studies of pts w/ #RRMM?
-
-
Mashup Score: 2RRMM — Current Activities - 6 month(s) ago
Riding the Wave | Differentiating Bispecifics and CAR-T for Relapsed Refractory Multiple Myeloma Expert Consult #1: Selecting BCMA- and GPRC5D-Directed Therapies This activity is jointly provided by Global Education Group and Bonum…
Source: www.bonumce.comCategories: General Medicine News, Hem/OncsTweet-
2/#MedTwitter #MMsM 🏅#CME➡️https://t.co/1p3o9jnnGx 🟢#PreSurvey Q 1️⃣ 📊Which of the following has demonstrated the longest median progression-free survival in phase1️⃣ studies of pts w/ #RRMM?
-
-
Mashup Score: 1X - 6 month(s) ago
Don’t miss what’s happeningPeople on X are the first to know.
Source: x.comCategories: General Medicine News, Hem/OncsTweet-
RT @NorthTxMSG: https://t.co/KYqVKzIbvy
-
-
Mashup Score: 1
Changing the Course of MyelomaDon’t miss this Detroit community event to discuss health empowerment. We will focus on awareness of multiple myeloma in the African American community and living a healthier life. The panel will share patient stories and suggestions to “M-Power” yourself if ever faced with a complicated diagnosis. Refreshments will be provided.
Source: web.cvent.comCategories: General Medicine News, Hem/OncsTweet-
RT @IMFmyeloma: Register Now for the November 4th #IMFMPOWER Community Workshop in #Detroit https://t.co/G7whW47rG3 At this M-Power Communi…
-
-
Mashup Score: 0
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: General Medicine News, Hematologists1Tweet-
@BonumCe @Global_CME @BSantomasso @MarcelaMaus @drkevinjcurran @drkomanduri @DrMvandenBrink @AlGarfall @CampagnaroErica @CohenAd_MMdoc @HarethNahi @AjaiChari @NBahlis @DrRakeshPopat @PerrotAurore @mvmateos @szusmani @ASTCT @Mohty_EBMT @abhinav_deol @AliciaAllred @AnnaSureda5 @betsyodonnellmd @Ccostello7 @DavidSSiegelMD @TomBmt133 @AjayNookaMD @myelomatips @RahulBanerjeeMD @YiLinMDPhD @End_myeloma @JoshuaRichterMD @MyelomaSLC @NoopurRajeMD @ravivij @SurbhiSidanaMD @HadidiSamer @OcioEnrique @paurotero @H_Einsele @CaersJo @profBigG @BroijlAnnemiek @YEfebera @SagarLonialMD @DrKrinaPatel @adsouza_md @HiraSMian 22/#mmsm🏆#CME🔗https://t.co/IV13FU8AQq 🔴#PostPoll 3️⃣ 57yoF presented with 🤒, hypoxia, & expressive aphasia on day 6 after cilta-cel infusion On levetiracetam to prevent seizures Diagnosed w grade 2 CRS & grade 1 ICANS 🔴Which tx is best? (Methylyprednisolone = methylpred.)
-
-
Mashup Score: 3HCM in IBD — Current Activities - 7 month(s) ago
Real-world Access to T cell-directed Therapies in Multiple Myeloma: Driving Away Health Disparities This activity is jointly provided by Global Education Group and Bonum CE. …
Source: Current ActivitiesCategories: Hematologists1, Latest HeadlinesTweet-
2/@BonumCE @Global_CME #mmsm ⚠️Important "need to know" items👇 1️⃣ - read CME ℹ️👉🏼https://t.co/W7S6rrN2FJ 2️⃣ - take the Pre-survey: https://t.co/vxR0PL3yeH 3️⃣ - get all the info 👇 4️⃣ - claim your 🏆 https://t.co/J2OJdRrcEP
-
Did u know incidence of #myeloma is >2️⃣x ⬆️in African American than in White ppl in🇺🇸? ☑️ out #mmsm Disparities & Access #MedTweetorial🧵w @MaiolinoAngelo & Me👋 🆓#CME 👉🏼 https://t.co/W7S6rrN2FJ Support by edu grants from @JanssenUS & @Pfizer 🏁First, what’s ur specialty?
-
RT @akeithstewart: Reunion dinner of the hematology biggest losers club https://t.co/LaqrHQo0Ez @Rfonsi1 @jmikhaelmd @Leif_Bergsagel Just m…